Outcome of Selective & Nonselective Caries Removal in Permanent Teeth
Launched by KING'S COLLEGE LONDON · Apr 18, 2024
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two methods of treating deep tooth decay in permanent teeth, called non-selective caries removal (NSCR) and selective caries removal (SCR). Both methods are commonly used by dentists but we want to see which one works better in keeping teeth healthy over time. Participants in the study will be divided into two groups: one will receive NSCR, and the other will have SCR. If a tooth has a problem with its inner pulp, both groups will also receive a treatment called Partial Pulpotomy. The success of these treatments will be checked at follow-up visits over 1, 3, and 5 years using X-rays to see how well the tooth is doing.
To be eligible for this trial, participants need to be at least 18 years old and have a deep cavity in a molar or premolar tooth. They should be in generally good health and able to give consent. Patients with certain conditions, such as swelling or severe gum disease, will not be included. Throughout the study, participants can expect regular check-ups to assess their tooth health and receive guidance from dental professionals. This research aims to help dentists make better treatment choices for patients with deep tooth decay.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Dental patients from routine dental care at ADC (Acute Dental Care) clinics, both undergraduate and postgraduate dental clinics in Guy's Hospital.
- • 2. Both male and female individuals aged 18 years and older.
- • 3. Capable of providing informed consent.
- • 4. Generally, in good overall health from a medical standpoint.
- • 5. Possess at least one molar or premolar tooth exhibiting a clinically significant deep carious lesion, with or without carious pulp exposure.
- • 6. Displaying signs and symptoms indicative of a normal pulp or reversible pulpitis.
- • 7. positive response to the cold test (refrigerated gas).
- • 8. Absence of spontaneous pain.
- • 9. Absence of periapical lesions, as determined by routine radiographic examination
- Exclusion Criteria:
- • 1. Presence of fistulas or swelling.
- • 2. Involvement of anterior teeth.
- • 3. Evidence of external or internal root resorption.
- • 4. Multiple teeth with carious lesions within the same quadrant.
- • 5. Pregnancy in women.
- • 6. Patients under the age of 18.
- • 7. Individuals unable to provide informed consent.
- • 8. Patients who have received antibiotics in the preceding month.
- • 9. Immunocompromised patients.
- • 10. Teeth with tooth surface loss resulting from traumatic parafunctional habits or teeth displaying craze lines.
- • 11. Caries located beneath the gingival margin .
- • 12. Teeth affected by periodontal issues, characterized by bone loss or severe gingival recession.
- • 13. Teeth with pulp exposure where operators cannot achieve hemostasis after applying a cotton pellet soaked with 2.5% sodium hypochlorite (NaOCl) for three cycles, with each cycle consisting of a 2-minute application of NaOCl.
- • 14. People with difficulty to understand the clinical trial concept, procedure and details including language barrier.
- • 15. participants who are involved in other research at the same period of our study.
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Francesco Mannoci, Professor
Principal Investigator
professor of endodontics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported